Harry W M Steinbusch Selected Research

UK 343,664

5/2012

Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harry W M Steinbusch Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 09/2021 - 05/2005
13	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 11/2002
5	Mental Disorders (Mental Disorder) 01/2016 - 12/2004
5	Anhedonia 01/2016 - 03/2009
5	Mood Disorders (Mood Disorder) 01/2014 - 10/2007
5	Memory Disorders (Memory Loss) 01/2013 - 12/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 04/2009
4	Cognitive Dysfunction 01/2017 - 11/2009
4	Body Weight (Weight, Body) 01/2014 - 10/2005
4	Amyloid Plaque 03/2013 - 04/2004
3	Huntington Disease (Huntington's Disease) 09/2021 - 10/2006
3	Nervous System Diseases (Neurological Disorders) 09/2021 - 01/2016
3	Infections 01/2016 - 09/2007
3	Panic Disorder (Panic Attack) 10/2013 - 03/2011
3	Infarction (Infarctions) 09/2011 - 01/2006
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2021 - 11/2013
2	Neuroinflammatory Diseases 06/2021 - 04/2017
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 05/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 01/2016
2	Tauopathies 01/2015 - 08/2011
2	Depressive Disorder (Melancholia) 09/2012 - 01/2010
2	Necrosis 10/2011 - 01/2007
2	Hepatitis C 03/2011 - 03/2009
2	Neoplasms (Cancer) 11/2010 - 03/2009
2	Birth Weight (Birth Weights) 01/2010 - 01/2008
2	Bipolar Disorder (Manic Depressive Psychosis) 09/2007 - 12/2004
1	Brain Diseases (Brain Disorder) 09/2021
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2021
1	Olfaction Disorders (Cacosmia) 06/2021
1	Hypothermia 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Hypertension (High Blood Pressure) 04/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2017
1	Non-alcoholic Fatty Liver Disease 05/2016
1	Seizures (Absence Seizure) 01/2016
1	Parkinsonian Disorders (Parkinsonism) 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Insulin Resistance 01/2014
1	Lordosis 01/2014
1	Stroke (Strokes) 11/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2013

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2015 - 03/2003
7	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 10/2007
5	Amyloid (Amyloid Fibrils)IBA 06/2021 - 04/2004
5	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 02/2006
5	Tryptophan (L-Tryptophan)FDA Link 01/2010 - 09/2007
4	Dopamine (Intropin)FDA LinkGeneric 04/2017 - 09/2010
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 12/2008
4	Scopolamine (Hyoscine)FDA Link 01/2013 - 03/2007
4	Amyloid beta-PeptidesIBA 09/2007 - 11/2002
3	Antidepressive Agents (Antidepressants)IBA 01/2016 - 09/2012
3	Sucrose (Saccharose)IBA 01/2016 - 03/2010
3	UbiquitinIBA 01/2015 - 08/2011
3	CytokinesIBA 03/2009 - 12/2004
3	Betamethasone (Celestone)FDA Link 07/2006 - 10/2005
2	Messenger RNA (mRNA)IBA 01/2020 - 11/2011
2	Levodopa (L Dopa)FDA LinkGeneric 04/2017 - 01/2016
2	2- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-oneIBA 01/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2007
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2016 - 01/2014
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015 - 10/2012
2	Insulin ReceptorIBA 01/2015 - 09/2012
2	LipopolysaccharidesIBA 01/2015 - 03/2012
2	polyglutamineIBA 01/2015 - 08/2011
2	CorticosteroneIBA 01/2014 - 04/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2014 - 01/2014
2	Insulin (Novolin)FDA Link 01/2014 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011 - 10/2011
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 09/2011 - 03/2007
2	Cholinergic Agents (Cholinergics)IBA 09/2011 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 09/2007
2	KynurenineIBA 03/2009 - 09/2007
1	VitaminsIBA 09/2021
1	Dual-Specificity PhosphatasesIBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 04/2019
1	SaltsIBA 04/2019
1	Desoxycorticosterone (Deoxycorticosterone)IBA 04/2019
1	Desoxycorticosterone Acetate (DOCA)FDA Link 04/2019
1	Anesthetics (Anesthetic Agents)IBA 01/2018
1	alpha-SynucleinIBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	CholesterolIBA 05/2016
1	LipidsIBA 05/2016
1	Toll-Like Receptor 4IBA 05/2016
1	RolipramIBA 01/2016
1	Quinolinic AcidIBA 01/2016
1	aminochrome 1 (aminochrome)IBA 01/2016
1	NeurotoxinsIBA 01/2016
1	GoldIBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	GlucocorticoidsIBA 01/2014
1	Drinking WaterIBA 01/2014
1	Blood Glucose (Blood Sugar)IBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 11/2013
1	Carbon DioxideIBA 10/2013
1	SynaptophysinIBA 03/2013

Therapy/Procedure

7	Therapeutics 01/2019 - 10/2007
6	Deep Brain Stimulation 01/2013 - 05/2005
1	Anesthesia 01/2018